Reported By:
| Edited By: |Source: Reuters |Updated: May 12, 2010, 12:27 PM IST
Cadila Healthcare Ltd said on Wednesday it has received approval from the rug controller general of India to market the H1N1 vaccine in the country.
The egg-based vaccine named 'VaxiFlu-S' will be marketed by Vaxxicare, a division of the company focusing on preventives, it said in a statement.
